Deaminases are enzymes that catalyze the hydrolysis of amino groups of nucleosides or their bases. Because these enzymes play important roles in nucleotide metabolism, they are relevant targets in anticancer and antibacterial therapies. Mammalian deaminases are commercially available but the use of bacterial whole cells, especially as biocatalysts, is continuously growing because of their economical benefits. Moreover, deaminases are useful for the preparative chemoenzymatic transformation of nucleoside and base analogues into a variety of derivatives. The purine deaminase activities of Arthrobacter oxydans, a gram-positive bacterium utilized widely in bioremediation, were studied. The presence of adenosine, adenine and guanine deaminases was demonstrated and some purine bases and nucleosides were analyzed as substrates. Using A. oxydans whole cells as the biocatalyst, different purine compounds such as the anti-HIV, 2 0 ,3 0 -dideoxyinosine (73%, 2 h) were obtained.
Introduction
Arthrobacter oxydans is a gram-positive aerobic coryneform bacterium, utilized widely in bioremediation because of its capacity to detoxify chromium (Asatiani et al., 2004) and nickel (Van Nostrand et al., 2007) and remove NH 3 from gas mixtures (Chung et al., 2005) . In addition, cells of A. oxydans in combination with cells of Pantotea agglomerans were used to degrade o-methoxybenzoate, a compound present in the waste produced during olive oil manufacturing (Gil et al., 2000) . Only one enzyme isolated from A. oxydans, the levan fructotransferase, was applied in biotransformations, as far as we know, for the preparation of the sweetener and chelating agent DFAIV (di-D-fructose dianhydride) (Jang et al., 2003) . Deaminases from this strain were not reported in the available literature.
Purine and pyrimidine deaminases play key roles in the nucleotide metabolism and have become important tools for anticancer and antibacterial therapies because deamination is the first committed step in the degradation and in the salvage pathways of nucleosides.
Deaminases are hydrolytic enzymes that naturally catalyze the hydrolysis of amino groups of nucleosides or their bases. Adenosine deaminase (ADA; EC 3.5.4.4) is the most used and widespread enzyme of this group and is commercially available from mammalian sources, mainly from calf spleen or calf intestine. It catalyzes the irreversible hydrolysis of adenosine to inosine and ammonia (Fig. 1I) , and its broad activity on base-or sugar-modified nucleosides is long since known (Ciuffreda et al., 2000) .
The structural characteristics that govern ADA substrate specificity are of considerable importance in the design of new nucleosides acting both as pharmaceutical agents and as ADA inhibitors. The three-dimensional structure of the enzyme and its deamination mechanism has added valuable information in that sense (Hernandez et al., 2002) . Ciuffreda et al. (2002) have shown that the 5 0 -hydroxyl group is required for ADA activity whereas modifications at 2 0 and 3 0 positions are well tolerated. Tritsch et al. (2000) have demonstrated that some 3 0 -analogues of adenine riboside and xyloside, carrying amino, azido, halogen or hydrogen, were deaminated by ADA.
The 6-substituted adenosines, like 6-chloro, 6-hydrazino, 6-methoxy and 6-methylamino purine ribosides, are also substrates of ADA with different degrees of efficacy. In addition, some 2,6-disubstituted purine nucleosides, carried at the 2-position, amino or alkyl groups, but not halides, can be deaminated by ADA (Yokozeki & Tsuji, 2000) . ADA can also be applied for the preparative chemoenzymatic transformation of adenosine analogues. For example, this chemoenzymatic strategy was successfully applied for the synthesis of 2 0 -O-methylguanosine (Sproat et al., 1991) , 2-acetonylinosine (Grupta & Nair, 2005) and (2 0 R)-and (Kawashima et al., 2006) . Only a few applications have been reported using isolated ADA from microorganisms even though they can be overexpressed easily (Okuyama et al., 2003) .
Adenine deaminases (AAH, EC 3.5.4.2) are also aminohydrolases that convert adenine into hypoxanthine (Fig. 1II ). They can be grouped into two families: fungal AAHs, closely related to the mammalian and bacterial ADA; and bacterial AAHs, which have close identity to other enzymes like allantoinase, urease and dihydroorotase from both eukaryotic and prokaryotic sources (Ribard et al., 2003) . Up to now, no AAH from higher eukaryotic organisms has been identified; adenine is converted to inosine monophosphate (IMP) predominantly through the formation of adenosine and hypoxanthine catalyzed by purine nucleoside phosphorylase (PNP), ADA and phosphoribosyltransferase (PRT). A minor alternative to metabolize adenine is the formation of ATP, which is converted via the histidine pathway to IMP (Deeley, 1992) .
The aminohydrolase responsible for the conversion of guanine to xanthine (Fig. 1III ) is guanine deaminase (GD, EC 3.5.4.3). Two types of GD have evolved separately. Plants, Caenorhabditis, Archaea and some bacterial GD, like the one from Bacillus subtilis, belong to the cytidine deaminase (CDA) superfamily. On the other hand, mammalian, insect, fungal and some bacterial GD, as that from Escherichia coli, are grouped into the metallohydrolase superfamily (Liaw et al., 2004) . In agreement with this distinction, the role of GD in purine metabolism is different.
GD is the only enzyme identified in mammals that can directly deaminate a base and is used as an indicator of hepatocellular disease and in the identification of blood infected with hepatitis C virus (Roberts & Newton, 2004) . High levels of GD have also been detected in cancerous kidney and breast cancer tissues; thus, potent GD inhibitors have been reported as potential drugs for treating these disorders (Ujjinamatada et al., 2006) . However, GD and PNP are probably involved in the apparent deamination of guanosine in human serum and tissue extracts to overcome the lack of guanosine deaminase (GDA, Fig. 1IV ). First, the ribose is split from guanosine by PNP forming guanine, which is then deaminated to xanthine by GD. Finally, PNP catalyzes the reaction that yields xanthosine.
Although bacterial whole cells have been used efficiently as biocatalysts, the application of whole-cell biocatalysts with deaminase activity had not been reported. Thus, the aim of this work was to study the ADA, AAH and GD activities of whole cells of A. oxydans and to analyze their substrate specificity.
Materials and methods

Chemicals and microorganisms
Nucleosides and bases were purchased from Sigma or ICN. The culture medium components were obtained from Merck and Difco. HPLC-grade methanol and acetonitrile were obtained from Carlo Erba. Arthrobacter oxydans and Aeromonas salmonicida were supplied by the Sociedad Española de Microbiología.
Growth conditions
Arthrobacter oxydans was cultured for two days at 26 1C in liquid medium containing per liter: beef extract 1 g, yeast extract 2 g, peptone 5 g, NaCl 5 g and distilled water, pH 7.2.
Aeromonas salmonicida was cultured for 1 day at 30 1C in a liquid medium containing per liter: beef extract 5 g, peptone 10 g, NaCl 5 g and distilled water, pH 7.2.
The saturated culture broths were centrifuged at 12 000 g for 10 min and the pellets were used as biocatalysts.
Deamination reactions
Purine nucleosides (10 mM) or 6-or 2,6-disubstituted purine bases (5 mM) in 30 mM, pH 7, potassium phosphate buffer were incubated with 1.0 Â 10 10 cells mL À1 of A. oxydans at 37 1C and 200 r.p.m. Samples were centrifuged and the supernatants were analyzed by HPLC.
Analytical methods
HPLC analysis was performed using a C-18 column (150 mm Â 4 mm) at a flow rate of 1 mL min À1 . The UV detector was set at 254 nm and the column was operated at room temperature. The other operating conditions were as follows: Nucleosides 2,6-diaminopurine riboside (DAPR), 2,6-diaminopurine 2 0 -deoxyriboside (dDAPR), guanosine and deoxyguanosine: 7 min water/acetonitrile (98 : 2 v/v), 3-min gradient to water/acetonitrile ( Dideoxyinosine, dideoxyadenosine, dideoxyguanosine and 2,6-diaminopurine-2 0 ,3 0 -dideoxyriboside: 10 min water/acetonitrile (90 : 10 v/v). Bases 2,6-Diaminopurine, guanine, xanthine: 6 min water/acetonitrile (97 : 3 v/v).
2-Amino-6-chloropurine: 7 min water/acetonitrile (97 : 3 v/v), 3-min gradient to water/acetonitrile (90 : 10 v/v), and 1 min water/acetonitrile (90 : 10 v/v).
2-Amino-6-mercaptopurine: 5 min water/acetonitrile (95 : 5 v/v). Synthesis of 2-amino-6-substituted purine nucleosides
2,6-Diaminopurine riboside
The reaction mixture comprising wet cell paste of A. salmonicida containing 1.1 Â 10 10 cells mL À1 , 10 mM 2,6-diaminopurine, 30 mM uridine and 30 mM, pH 7, potassium phosphate buffer was stirred at 200 r.p.m. and 60 1C.
After 1 h, the mixture was centrifuged, and the supernatant was quantified by HPLC. 2,6-Diaminopurine riboside was obtained in 95% yield.
2-Amino-6-chloropurine riboside
The reaction mixture comprising wet cell paste of A. salmonicida containing 1.1 Â 10 10 cells mL
À1
, 10 mM 2-amino-6-chloropurine, 30 mM uridine and 30 mM, pH 7, potassium phosphate buffer was stirred at 200 r.p.m. and 60 1C. After 3 h, the mixture was centrifuged, and the supernatant was quantified by HPLC. 2-Amino-6-chloropurine riboside was obtained in 75% yield.
2-Amino-6-methoxypurine riboside
À1
, 10 mM 2-amino-6-methoxypurine, 30 mM uridine and 30 mM, pH 7, potassium phosphate buffer was stirred at 200 r.p.m. and 60 1C. After 4 h, the mixture was centrifuged, and the supernatant was quantified by HPLC. 2-Amino-6-methoxypurine riboside was obtained in 90% yield.
2-Amino-6-mercaptopurine riboside
À1
, 5mM 2-amino-6-mercaptopurine, 15 mM uridine and 30 mM, pH 7, potassium phosphate buffer was stirred at 200 r.p.m. and 60 1C. After 5 h, the mixture was centrifuged, and the supernatant was quantified by HPLC. 2-Amino-6-mercaptopurine riboside was obtained in 72% yield.
Results and discussion
At present, there is a great interest in the preparation of guanine nucleoside analogues because they are efficient antiviral and anticancer agents. The industry also requires new sources of guanosine because both natural and synthetic supplies are insufficient (Horinouchi et al., 2003) . Some strategies have already been assessed in order to provide alternative routes (Lewkowicz & Iribarren, 2006) .
The most effective approach was achieved by the combination of transglycosylation and deamination reactions. Thus, starting from 2-amino-6-substituted purine bases and 2 0 -deoxyuridine or thymidine, several 2 0 -deoxyguanosine derivatives have been synthesized using bacterial whole cells containing nucleoside phosphorylases (Yokozeki & Tsuji, 2000) or isolated deoxyribosyltransferases (Okuyama et al., 2003) . Once the nucleosides were formed, the mammalian ADA catalyzed the hydrolysis of the 6-substituent, producing 2 0 -deoxyguanosine. In this work, we explored the capacity of whole cells of A. oxydans, selected from our cell collection because of its high ADA activity, to carry out the deamination of purine nucleosides and their bases.
To assess the ability of A. oxydans ADA to hydrolyze 2-amino-6-substituted purine ribosides, some compounds of this family were prepared. The optimal conditions for each nucleoside preparation are shown in Table 1 . In addition, 2,6-diaminopurine and adenine nucleosides carrying different sugar moieties, synthesized previously in our laboratory by microbial transglycosylation (Fig. 2) (Rogert et al., 2002; Médici et al., 2006) , were used for testing the sugar acceptance of A. oxydans ADA. The results of the deamination reactions are shown in Table 2 .
Depending on the base and the sugar residue, different yields and different reaction times were observed. In agreement with previous reports (Wilson & Quiocho, 1993) , which suggest that 6-SH derivatives act as an inhibitor of mammalian ADA, 2-amino-6-mercaptopurine riboside was the only nucleoside that was not hydrolyzed by A. oxydans ADA.
Adenine nucleosides are better substrates than are 2,6-disubstituted purine nucleosides, reflecting a higher enzymatic activity. On the other hand, guanosine yield is higher than the inosine one, which may be attributed to the hydrolytic effect of A. oxydans PNP on ribo-and deoxyribonucleosides, especially inosine and adenosine. The only exception was when 2-amino-6-methoxypurine riboside was the substrate. The low guanosine yield could be the result of PNP activity over that compound. Xanthine was observed as a byproduct. Because of the fact that arabinosides are poorer substrates for A. oxydans PNP than are ribosides, higher yields of arabinoinosine and arabinoguanosine were obtained, but the reaction times were higher. Besides, taking advantage of the finding that dideoxynucleosides are not substrates of this enzyme, the synthesis of 2 0 ,3 0 -dideoxyinosine and 2 0 ,3 0 -dideoxyguanosine was also assessed by this procedure. The preparation of both compounds showed significant differences in yields and reaction times, showing that both the sugar and the base structures affect the overall reaction productivity.
The hypoxanthine present in the deamination of adenosine may be alternatively explained by the probable existence of AAH activity in A. oxydans whole cells. This observation was confirmed by carrying out the deamination of adenine. Hypoxanthine was formed quantitatively in 2 h. The substrate acceptance was also assayed, testing some 6-substituted purines (Table 3) . We verified that AAH from A. oxydans could accept some 6-modified purines such as amino, chloro and methoxy purine. 6-Mercaptopurine was not a substrate for A. oxydans AAH (the same result was reported for ADA) and the ring-modified 8-azaadenine was the other base that was not accepted. This is the first substrate specificity study carried out for AAH, to our knowledge.
As mentioned above, during the synthesis of guanosine from 2-amino-6-methoxypurine riboside, xanthine was identified as a byproduct. This result is in agreement with the combined action of PNP, AAH and GD. The deamination of guanine was then performed, and 100% of xanthine was produced in 1 h, which revealed the GD activity of A. oxydans. Therefore, the selectivity of A. oxydans GD for some other bases was analyzed (Table 4) . Regarding 2-amino-6-substituted purines, 2,6-diaminopurine and 2-amino-6-chloropurine first produced guanine as a result of AAH activity, while 2-amino-6-methoxypurine produced only xanthine. The former result may suggest that guanine could not be the only substrate of A. oxydans GD. However, this supposition can only be confirmed by the isolation of the enzyme. Additionally, neither 2-amino-6-mercaptopurine nor 2-aminopurine or 7-deazaguanine were substrates, showing that both A. oxydans GD and AAH are sensitive to some purine modifications.
As expected, only a few reports were found in plants; no evidence of the presence of GDA was observed. Nevertheless, this could not be confirmed by this methodology. Xanthosine was never detected when 2,6-disubstituted purine ribosides were deaminated by A. oxydans. To verify this, an assay using guanosine as a GDA substrate was performed and again xanthosine was not observed, but only xanthine was produced. Thus, xanthine could be a result of two possible enzymatic pathways. One alternative is the phosphorolysis of guanosine by PNP and subsequent guanine deamination by GD. The other one is the deamination of guanosine performed by GDA, and then the fast action of PNP over the xanthosine produced.
It is well known that ADA from mammals and from the majority of bacteria loses its activity over 55 1C (Lewkowicz & Iribarren, 2006). One peculiarity of A. oxydans ADA and AAH is that they were still active when the reactions were carried out at 60 1C. In summary, this is the first report of the deaminase activity of A. oxydans. It is also the first report of the use of this bacterium as a whole-cell biocatalyst. From the experiments carried out with nucleosides and bases, ADA, AAH and GD activities were detected.
Using A. oxydans as the ADA source it was possible to obtain pharmacologically active compounds such as arabinoguanosine and 2 0 ,3 0 -dideoxyinosine. Arabinoguanosine is a powerful anti-leukemic agent whereas the 2 0 ,3 0 -dideoxyinosine is an effective Hepatitis B Virus and HIV inhibitor. Arthrobacter oxydans was also used in combination with other microorganisms to prepare guanosine analogues from less expensive pyrimidine nucleosides by the combined action of transglycosylation and by deamination.
Finally, A. oxydans could be used either as a source of ADA, AAH and GD or as a whole-cell biocatalyst in the deamination of nucleosides that are poor substrates for its PNP. In order to further characterize A. oxydans deaminases, the isolation of these enzymes is in progress.
